Business
Politics
Stocks
Investing

Business
Politics
Stocks
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025

June 4, 2025

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post

Operational Update

next post

Mali Court Adjourns Barrick’s Gold Complex Hearing Over Deepening Taxes, Control Dispute

Related Posts

Corporate Funding Update

September 3, 2025

Bitcoin: A Price History of the First Cryptocurrency

August 6, 2025

Biggest US Defense Contractors and ETFs in 2025

July 16, 2025

Sranan Gold Samples Additional High-Grade Gold Mineralization at...

August 1, 2025

Crypto Market Update: Stablecoins Top US$283 Billion in...

August 31, 2025

Trump Admin Strips “Safety” from AI Oversight Institute...

June 6, 2025

Silver Price Surges Above US$40 for First Time...

September 3, 2025

Earthwise Minerals Completes Phase 1 Field Program at...

August 26, 2025

Angkor Resources Advances Seismic Program With Enercam’s Oil...

August 15, 2025

Altech Batteries LtdCerenergy Battery Project Funding Progressing Well

July 23, 2025

Recent

Pastor recalls last moments with Charlie Kirk: ‘American martyr’
Ryan Routh chastised during opening statements in federal trial for ‘making a mockery’ of the court
Israel’s strike in Qatar triggers rare US rebuke, tests Trump’s Gulf diplomacy
Secret Service under pressure: What Kirk’s assassination means for Trump’s security
What is a bolt action rifle? What we know about the gun used to kill Charlie Kirk
Senate GOP hurtles toward nuclear option after deal with Dems falls apart

Categories

Business (157)
Investing (748)
Politics (859)
Stocks (119)

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 redwoodinvestreport.com | All Rights Reserved